Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial Of Pemetrexed Disodium And Gemcitabine In Advanced Urothelial Cancer

NCT00053209 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.

NCT NCT00053209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00053209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial Of Pemetrexed Disodium And Gemcitabine In Advanced Urothelial Cancer
Lead sponsor
Eastern Cooperative Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
August 10, 2004
Completion date
May 31, 2009
Enrollment
46 (actual)
Sites
121

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, transitional cell cancer of the renal pelvis and ureter, urethral cancer